Current pharmacotherapeutic options for primary dyslipidemia in adults
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2019.1604687
Abstract: ABSTRACT Introduction: Atherosclerotic cardiovascular disease (ASCVD) and its clinical manifestations, remain a leading cause of death and disability worldwide. One of the major risk factors of ASCVD is dyslipidemia and all the available guidelines suggest… read more here.
Keywords: primary dyslipidemia; current pharmacotherapeutic; treatment; pharmacotherapeutic options ... See more keywords
Prospective Registry Study of Primary Dyslipidemia (PROLIPID): Rationale and Study Design.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of atherosclerosis and thrombosis"
DOI: 10.5551/jat.63222
Abstract: INTRODUCTION Primary dyslipidemias are inherited disorders in plasma lipoprotein metabolism that lead to serious cardiovascular and other complications. The Japanese Ministry of Health, Labor and Welfare (MHLW) covers medical expenses, under the Research Program on… read more here.
Keywords: primary dyslipidemia; registry study; study primary; study ... See more keywords